Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

Immunology

Volumn 117, Issue 1, 2006, Pages 78-88

  Shen, Hong ^a   Ackerman, Anne L ^b   Cody, Virginia ^b   Giodini, Alessandra ^b   Hinson, Ella R ^b   Cresswell, Peter ^b   Edelson, Richard L ^b   Saltzman, W Mark ^a   Hanlon, Douglas J ^b  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation processing; Dendritic cells; Vaccination

Indexed keywords

ANTIGEN; INTERLEUKIN 2; LATEX; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PEPTIDE DERIVATIVE; POLYGLACTIN; SERYLISOLEUCYLISOLEUCYLASPARAGYLPHENYLALANYLGLUTAMINYLLYSYLLEUCINE; UNCLASSIFIED DRUG; BIOMATERIAL; BOVINE SERUM ALBUMIN; HLA ANTIGEN CLASS 2; LACTIC ACID; NANOMATERIAL; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BIODEGRADABILITY; BONE MARROW; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; CYTOSOL; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; MOUSE; NANOPARTICLE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOREMEDIATION; C57BL MOUSE; CELL LINE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CELL LINE; CROSS-PRIMING; DENDRITIC CELLS; ENDOSOMES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LACTIC ACID; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; OVALBUMIN; POLYGLYCOLIC ACID; POLYMERS; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES;

EID: 33644831362     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2005.02268.x     Document Type: Article

References (62)

1. + T cell responses to infectious agents, tumors, transplants, and vaccines Adv Immunol 1999 73 1 77
2. Bevan MJ Cross-priming for a secondary cytotoxic response to minor H-antigens with H-2 congenic cells which do not cross-react in cytotoxic assay J Exp Med 1976 143 1283 8
3. Heath WR Belz GT Behrens GMN et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens Immunol Rev 2004 199 9 26
4. Huang AYC Golumbek P Ahmadzadeh M Jaffee E Pardoll D Levitsky H Role of bone-marrow-derived cells in presenting MHC class I-restricted tumor-antigens Science 1994 264 961 5
5. Sigal LJ Crotty S Andino R Rock KL Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen Nature 1999 398 77 80
6. Rock KL Gamble S Rothstein L Presentation of exogenous antigen with class-I major histocompatibility complex molecules Science 1990 249 918 21
7. Moron G Dadaglio G Leclerc C New tools for antigen delivery to the MHC class I pathway Trends Immunol 2004 25 92 7
8. Harding CV Song R Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class-I MHC molecules J Immunol 1994 153 4925 33
9. Rock KL Clark K Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway J Immunol 1996 156 3721 6
10. Foged C Sundblad A Hovgaard L Targeting vaccines to dendritic cells Pharm Res 2002 19 229 38
11. Little SR Lynn DM Ge Q Anderson DG Puram SV Chen J Eisen HN Langer R Poly-α amino ester-containing microparticles enhance the activity of nonviral genetic vaccines Proc Natl Acad Sci USA 2004 101 9534 9
12. Mahoney MJ Saltzman WM Transplantation of brain cells assembled around a programmable synthetic microenvironment Nat Biotech 2001 19 934 9
13. Maheshwari A Han S Mahato RI Kim SW Biodegradable polymer-based interleukin-12 gene delivery: Role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity Gene Ther 2002 9 1075 84
14. Waeckerle-Men Y Gander B Groettrup M Delivery of tumor antigens to dendritic cells using biodegradable microspheres Methods Mol Med 2005 109 35 46
15. Panyam J Labhasetwar V Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv Drug Del Rev 2002 55 329 47
16. Raychaudhuri S Rock KL Fully mobilizing host defense: Building better vaccines Nat Biotech 1998 16 1025 31
17. Partidos CD Vohra P Jones D Farrar G Steward MW CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles J Immunol Methods 1997 206 143 51
18. Partidos CD Vohra P Jones DH Farrar G Steward MW Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles J Cont Rel 1999 62 325 32
19. Partidos CD Vohra P Steward MW Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides Immunology 1996 87 179 85
20. Nixon DF Hioe C Chen PD et al. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity Vaccine 1996 14 1523 30
21. Lutsiak ME Robinson DR Coester C Kwon GS Samuel J Analysis of poly ( d, l -lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro Pharm Res 2002 19 1480 7
22. Newman KD Elamanchili P Kwon GS Samuel J Uptake of poly ( d, l -lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo J Biomed Mater Res 2002 60 480 6
23. Denis-Mize KS Dupuis M MacKichan ML et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells Gene Ther 2000 7 2105 12
24. Audran R Peter K Dannull J Men Y Scandella E Groettrup M Gander B Corradin G Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro Vaccine 2003 21 1250 5
25. Sun H Pollock KG Brewer JM Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro Vaccine 2003 21 849 55
26. Haining WN Anderson DG Little SR et al. pH-triggered microparticles for peptide vaccination J Immunol 2004 173 2578 85
27. Mocellin S Mandruzzato S Bronte V Lise M Nitti D Part I. Vaccines for solid tumours Lancet Oncol 2004 5 681 9
28. Stift A Friedl J Dubsky P et al. Dendritic cell-based vaccination in solid cancer J Clin Oncol 2003 21 135 42
29. Geiger JD Hutchinson RJ Hohenkirk LF et al. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression Cancer Res 2001 61 8513 9
30. Fifis T Gamvrellis A Crimeen-Irwin B Pietersz GA Li J Mottram PL McKenzie IF Plebanski M Size-dependent immunogenicity. therapeutic and protective properties of nano-vaccines against tumors J Immunol 2004 173 3148 54
31. St Louis DC Woodcock JB Fransozo G et al. Evidence for distinct intracellular signaling pathways in CD34 (+) progenitor to dendritic cell differentiation from a human cell line model J Immunol 1999 162 3237 48
32. Ackerman AL Cresswell P Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1 J Immunol 2003 170 4178 88
33. Alexander J Payne JA Murray R Frelinger JA Cresswell P Differential transport requirements of HLA and H-2 class-I glycoproteins Immunogenetics 1989 29 380 8
34. Anderson KS Alexander J Wei M Cresswell P Intracellular-transport of class-I MHC molecules in antigen-processing mutant-cell lines J Immunol 1993 151 3407 19
35. Inaba K Inaba M Romani N Aya H Deguchi M Ikehara S Muramatsu S Steinman RM Generation of large numbers of dendritic cells from mouse bone-marrow cultures supplemented with granulocyte macrophage colony-stimulating factor J Exp Med 1992 176 1693 702
36. Saltzman WM Mak MW Mahoney MJ Duenas ET Cleland JL Intracranial delivery of recombinant nerve growth factor: Release kinetics and protein distribution for three delivery systems Pharm Res 1999 16 232 40
37. Moynihan JS Jones DH Farrar GH Howard CR A novel microencapsulated peptide vaccine against hepatitis B Vaccine 2001 19 3292 300
38. Porgador A Yewdell JW Deng YP Bennink JR Germain RN Localization, quantitation, and in situ detection of specific peptide MHC class I complexes using a monoclonal antibody Immunity 1997 6 715 26
39. Hammond C Denzin LK Pan M Griffith JM Geuze HJ Cresswell P The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR-DM, and -DO molecules J Immunol 1998 161 3282 91
40. Hosken NA Bevan MJ Defective presentation of endogenous antigen by a cell-line expressing class-I molecules Science 1990 248 367 70
41. Yang JB Beitz DC A fluorometric assay for cholesterol reductase-activity Anal Biochem 1992 206 246 50
42. Heit A Huster KM Schmitz F Schiemann M Busch DH Wagner H CPG-DNA aided cross-priming by cross-presenting B cells J Immunol 2004 172 1501 7
43. Ke Y Kapp JA Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake J Exp Med 1996 184 1179 84
44. Via LE Fratti RA McFalone M Pagan-Ramos E Deretic D Deretic V Effects of cytokines on mycobacterial phagosome maturation J Cell Sci 1998 111 897 905
45. Blander JM Medzhitov R Regulation of phagosome maturation by signals from toll-like receptors Science 2004 304 1014 8
46. Rock KL A new foreign policy: MHC class I molecules monitor the outside world Immunol Today 1996 17 131 7
47. Ackerman AL Cresswell P Cellular mechanisms governing cross-presentation of exogenous antigens Nat Immunol 2004 5 678 84
48. Shen L Sigal LJ Boes M Rock KL Important role of cathepsin S in generating peptides for TAP-independent MHC class I cross presentation in vivo Immunity 2004 21 155 65
49. + Th1 cells Vaccine 1995 13 1741 9
50. Newman KD Kwon GS Miller GG Chlumecky V Samuel J Cytoplasmic delivery of a macromolecular fluorescent probe by poly ( d, l -lactic-co-glycolic acid) microspheres J Biomed Mat Res 2000 50 591 7
51. Panyam J Zhou WZ Prabha S Sahoo SK Labhasetwar V Rapid endo-lysosomal escape of poly ( d, l -lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery FASEB J 2002 16 1217 26
52. Ludewig B McCoy K Pericin M et al. Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells J Immunol 2001 166 3678 87
53. Wang RF Wang HY Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells Nat Biotech 2002 20 149 54
54. Parkhurst MR Salgaller ML Southwood S Robbins PF Sette A Rosenberg SA Kawakami Y Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen GP100 modified at HLA-A*0201-binding residues J Immunol 1996 157 2539 48
55. Rosenberg SA Yang JC Schwartzentruber DJ et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Nat Med 1998 4 321 7
56. Slansky JE Rattis FM Boyd LF Fahmy T Jaffee EM Schneck JP Margulies DH Pardoll DM Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex Immunity 2000 13 529 38
57. Palinko-Biro E Ronaszeki G Merkle HP Gander B Release kinetics and immunogenicity of parvovirus microencapsulated in PLA/PLGA microspheres Int J Pharmaceut 2001 221 153 7
58. Panyam J Dali MA Sahoo SK Ma WX Chakravarthi SS Amidon GL Levy RJ Labhasetwar V Polymer degradation and in vitro release of a model protein from poly ( d, l -lactide-co-glycolide) nano- and microparticles J Cont Rel 2003 92 173 87
59. Morita T Sakamura Y Horikiri Y Suzuki T Yoshino H Protein encapsulation into biodegradable microspheres by a novel s/o/w emulsion method using poly (ethylene glycol) as a protein micronization adjuvant J Cont Rel 2000 69 435 44
60. Thumann P Moc I Humrich J Berger TG Schultz ES Schuler G Jenne L Antigen loading of dendritic cells with whole tumor cell preparations J Immunol Methods 2003 277 1 16
61. Parmiani G Pilla L Castelli C Rivoltini L Vaccination of patients with solid tumours Anal Oncol 2003 14 817 24
62. Shen ZH Reznikoff G Dranoff G Rock KL Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules J Immunol 1997 158 2723 30